語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
FindBook
Google Book
Amazon
博客來
Adverse Effects of Treatment for Rectal Cancer : = Sexual Function, Hormones, And Bone Health.
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Adverse Effects of Treatment for Rectal Cancer :/
其他題名:
Sexual Function, Hormones, And Bone Health.
作者:
Rojvall, Annika Svanstrom.
面頁冊數:
1 online resource (104 pages)
附註:
Source: Dissertations Abstracts International, Volume: 84-06, Section: A.
Contained By:
Dissertations Abstracts International84-06A.
標題:
Free radicals. -
電子資源:
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30191825click for full text (PQDT)
ISBN:
9798358416949
Adverse Effects of Treatment for Rectal Cancer : = Sexual Function, Hormones, And Bone Health.
Rojvall, Annika Svanstrom.
Adverse Effects of Treatment for Rectal Cancer :
Sexual Function, Hormones, And Bone Health. - 1 online resource (104 pages)
Source: Dissertations Abstracts International, Volume: 84-06, Section: A.
Thesis (Ph.D.)--Karolinska Institutet (Sweden), 2022.
Includes bibliographical references
Thanks to improved outcomes from multimodal rectal cancer (RC) treatment, long-term survival is increasing; thus, focus on the long-term adverse effects of treatment is required. This thesis aimed to increase knowledge regarding adverse effects to enable well-informed treatment decisions and accurate management of the side effects. Studies I-IV were part of a multicentre, prospective cohort study including 142 females with RC stage I-III from 2008 to 2013. Clinical data and blood samples for hormone and bone biomarker analysis were collected at baseline, after (chemo)radiotherapy (C)RT, and at one year. Questionnaires on sexual function (Female Sexual Function Index; FSFI) and psychological well-being were completed at baseline and one- and two-year follow-up, and on bowel function at two years.Female androgens are produced in the ovaries, adrenals and by peripheral conversion. Study I explored the impact of preoperative RT on ovarian androgen production and the association between androgens and sexual desire. Testosterone (T), free T, androstenedione (A-4), and dehydroepiandrosterone sulfate (DHEAS) were assessed and compared between non-oophorectomized females treated with RT and surgery (RT+) vs surgery alone (RT-) (N=125). Radiotherapy was associated with a decrease in the androgens predominantly produced in the ovaries (T and free T). Changes in serum levels of all measured androgens were associated with sexual desire.Rectal cancer treatment negatively affects sexual function, with data being more robust for males than females. Study II aimed to assess sexual function and its association with RT in females. The FSFI scores were assessed in all women who completed the questionnaire at least once during the two years follow-up (N=139). Total and domain scores were compared within and between the treatment groups (RT+ vs RT-), and the associations between RT and change in FSFI scores were explored in multivariable models. Radiotherapy was associated with a decline in FSFI total score and the domain scores of arousal, lubrication, orgasm, and pain. A secondary aim was to assess ovarian reserve. Anti-Mullerian hormone was measured in premenopausal females (N=9) and became undetectable after RT.Data indicate that androgens are important for female sexual function. The role of endogenous androgen levels in sexual function was not previously investigated in females with RC. Study III explored the association between endogenous levels of the four androgens specified above and FSFI scores among sexually active females (N=99). Increasing levels of T and A-4 were associated with increased FSFI total score, and at least any of T, free T, and A-4 were associated with the FSFI domains of sexual arousal, lubrication, orgasm, or pain.Pelvic insufficiency fractures are a complication of RT for RC. Serum bone biomarkers reflecting the bone remodelling process have been suggested as useful in assessing bone health. Study IV assessed four bone biomarkers in 134 participants, explored their changes after RC treatment, and if the changes were associated with RT. The prevalence of bone damage was evaluated in a subgroup with magnetic resonance imaging (N=41). Two bone formation markers increased significantly in the RT group between baseline and one year. In the multivariable analysis, RT was associated with an increased level of one of these markers. Bone damage was present in 16 of 38 females who had RT in the subgroup.Study V investigated if patients were given information regarding sexual side effects. Two surveys were directed at physicians and RC patients, respectively; the numbers participating were 186 and 253. Among physicians, approximately half reported that they addressed sexual side effects before treatment, with more than half of the patients and more males than females. Almost half of the patients recalled getting information before treatment. High age, poor physical status among patients, and short clinical experience among physicians decreased the odds of information being provided.In conclusion, the results indicate that RT negatively affects sexual function, androgens, and bone health and show room for improvement in the pre-treatment information about and follow-up of sexual side effects with patients.
Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023
Mode of access: World Wide Web
ISBN: 9798358416949Subjects--Topical Terms:
3682274
Free radicals.
Index Terms--Genre/Form:
542853
Electronic books.
Adverse Effects of Treatment for Rectal Cancer : = Sexual Function, Hormones, And Bone Health.
LDR
:05898nmm a2200505K 4500
001
2365726
005
20231218204650.5
006
m o d
007
cr mn ---uuuuu
008
241011s2022 xx obm 000 0 eng d
020
$a
9798358416949
035
$a
(MiAaPQ)AAI30191825
035
$a
(MiAaPQ)Karolinska_1061648210
035
$a
AAI30191825
040
$a
MiAaPQ
$b
eng
$c
MiAaPQ
$d
NTU
100
1
$a
Rojvall, Annika Svanstrom.
$3
3706594
245
1 0
$a
Adverse Effects of Treatment for Rectal Cancer :
$b
Sexual Function, Hormones, And Bone Health.
264
0
$c
2022
300
$a
1 online resource (104 pages)
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
500
$a
Source: Dissertations Abstracts International, Volume: 84-06, Section: A.
500
$a
Advisor: Segelman, Josefin;Martling, Anna;Buchli, Christian;Radestad, Angelique Floter.
502
$a
Thesis (Ph.D.)--Karolinska Institutet (Sweden), 2022.
504
$a
Includes bibliographical references
520
$a
Thanks to improved outcomes from multimodal rectal cancer (RC) treatment, long-term survival is increasing; thus, focus on the long-term adverse effects of treatment is required. This thesis aimed to increase knowledge regarding adverse effects to enable well-informed treatment decisions and accurate management of the side effects. Studies I-IV were part of a multicentre, prospective cohort study including 142 females with RC stage I-III from 2008 to 2013. Clinical data and blood samples for hormone and bone biomarker analysis were collected at baseline, after (chemo)radiotherapy (C)RT, and at one year. Questionnaires on sexual function (Female Sexual Function Index; FSFI) and psychological well-being were completed at baseline and one- and two-year follow-up, and on bowel function at two years.Female androgens are produced in the ovaries, adrenals and by peripheral conversion. Study I explored the impact of preoperative RT on ovarian androgen production and the association between androgens and sexual desire. Testosterone (T), free T, androstenedione (A-4), and dehydroepiandrosterone sulfate (DHEAS) were assessed and compared between non-oophorectomized females treated with RT and surgery (RT+) vs surgery alone (RT-) (N=125). Radiotherapy was associated with a decrease in the androgens predominantly produced in the ovaries (T and free T). Changes in serum levels of all measured androgens were associated with sexual desire.Rectal cancer treatment negatively affects sexual function, with data being more robust for males than females. Study II aimed to assess sexual function and its association with RT in females. The FSFI scores were assessed in all women who completed the questionnaire at least once during the two years follow-up (N=139). Total and domain scores were compared within and between the treatment groups (RT+ vs RT-), and the associations between RT and change in FSFI scores were explored in multivariable models. Radiotherapy was associated with a decline in FSFI total score and the domain scores of arousal, lubrication, orgasm, and pain. A secondary aim was to assess ovarian reserve. Anti-Mullerian hormone was measured in premenopausal females (N=9) and became undetectable after RT.Data indicate that androgens are important for female sexual function. The role of endogenous androgen levels in sexual function was not previously investigated in females with RC. Study III explored the association between endogenous levels of the four androgens specified above and FSFI scores among sexually active females (N=99). Increasing levels of T and A-4 were associated with increased FSFI total score, and at least any of T, free T, and A-4 were associated with the FSFI domains of sexual arousal, lubrication, orgasm, or pain.Pelvic insufficiency fractures are a complication of RT for RC. Serum bone biomarkers reflecting the bone remodelling process have been suggested as useful in assessing bone health. Study IV assessed four bone biomarkers in 134 participants, explored their changes after RC treatment, and if the changes were associated with RT. The prevalence of bone damage was evaluated in a subgroup with magnetic resonance imaging (N=41). Two bone formation markers increased significantly in the RT group between baseline and one year. In the multivariable analysis, RT was associated with an increased level of one of these markers. Bone damage was present in 16 of 38 females who had RT in the subgroup.Study V investigated if patients were given information regarding sexual side effects. Two surveys were directed at physicians and RC patients, respectively; the numbers participating were 186 and 253. Among physicians, approximately half reported that they addressed sexual side effects before treatment, with more than half of the patients and more males than females. Almost half of the patients recalled getting information before treatment. High age, poor physical status among patients, and short clinical experience among physicians decreased the odds of information being provided.In conclusion, the results indicate that RT negatively affects sexual function, androgens, and bone health and show room for improvement in the pre-treatment information about and follow-up of sexual side effects with patients.
533
$a
Electronic reproduction.
$b
Ann Arbor, Mich. :
$c
ProQuest,
$d
2023
538
$a
Mode of access: World Wide Web
650
4
$a
Free radicals.
$3
3682274
650
4
$a
Mutation.
$3
837917
650
4
$a
Cancer therapies.
$3
3557730
650
4
$a
Chemical reactions.
$3
519248
650
4
$a
DNA damage.
$3
916185
650
4
$a
Physicians.
$3
667368
650
4
$a
Hypoxia.
$3
3561738
650
4
$a
Fractionation.
$3
3706595
650
4
$a
Energy.
$3
876794
650
4
$a
Colorectal cancer.
$3
3562591
650
4
$a
Androgens.
$3
3699924
650
4
$a
Apoptosis.
$3
600650
650
4
$a
Cell cycle.
$3
766119
650
4
$a
Schedules.
$3
3564128
650
4
$a
Patients.
$3
1961957
650
4
$a
Surgery.
$3
707153
650
4
$a
Charged particles.
$3
3682557
650
4
$a
Lymphatic system.
$3
3685740
650
4
$a
Magnetic resonance imaging.
$3
554355
650
4
$a
Gamma rays.
$3
3217214
650
4
$a
Biomarkers.
$3
2205735
650
4
$a
Tumors.
$3
893964
650
4
$a
Radiation therapy.
$3
3557731
650
4
$a
Chemotherapy.
$3
728559
650
4
$a
Cell division.
$3
816756
650
4
$a
Atomic physics.
$3
3173870
650
4
$a
Biochemistry.
$3
518028
650
4
$a
Cellular biology.
$3
3172791
650
4
$a
Chemistry.
$3
516420
650
4
$a
Developmental biology.
$3
592588
650
4
$a
Endocrinology.
$3
610914
650
4
$a
Medical imaging.
$3
3172799
650
4
$a
Medical personnel.
$2
itrt.
$3
774747
650
4
$a
Medicine.
$3
641104
650
4
$a
Nuclear physics.
$3
517741
650
4
$a
Oncology.
$3
751006
650
4
$a
Pharmaceutical sciences.
$3
3173021
650
4
$a
Physics.
$3
516296
650
4
$a
Therapy.
$3
3343697
655
7
$a
Electronic books.
$2
lcsh
$3
542853
690
$a
0791
690
$a
0576
690
$a
0748
690
$a
0487
690
$a
0379
690
$a
0485
690
$a
0758
690
$a
0409
690
$a
0574
690
$a
0207
690
$a
0564
690
$a
0756
690
$a
0992
690
$a
0572
690
$a
0605
690
$a
0212
710
2
$a
ProQuest Information and Learning Co.
$3
783688
710
2
$a
Karolinska Institutet (Sweden).
$3
3557748
773
0
$t
Dissertations Abstracts International
$g
84-06A.
856
4 0
$u
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30191825
$z
click for full text (PQDT)
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9488082
電子資源
11.線上閱覽_V
電子書
EB
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入